Study found DNA-based screen was more than 90 percent accurate in predicting recurrence
This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Study of Taiwanese patients found potential dangers in aristolochia
Thu Apr 19, 2012 09:22 PM
No doubt big Pharma paid for the tests. Anything that is natural is not aloud to be seen as benificial. It may impact on their profits.
Fri Apr 20, 2012 04:32 AM
aristolochic acid has not been used in this country for 20 years. this is such an old story that is dragged out every few years by the drug industry to get the heat off of them. I would look into who funded this useless study
We care about your feedback. Let us know how we can improve your CancerCompass experience.